The discovery of TVS-23 and its more potent analogues expands the diversity of Hsp90 CTD scaffolds and proves that structure-based virtual screening is a successful tool for discovering novel Hsp90 CTD inhibitors with antiproliferative activity in various cancer cell lines. The gene discussed is HSP90AB1; the disease is cancer.